paxalisib — Topline data
early 2027
Kazia continues to anticipate the targeted enrollment of twelve TNBC pts target by the end of 2026 and topline data readout in early 2027Source filing
KZIA biotech catalysts & pipeline
KAZIA THERAPEUTICS LTD · Data as of 2026-09-08